Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CACNA2D1 | P54289 | 1/20 | 0.39 |
| ▸ | CACNB2 | Q08289 | 1/20 | 0.39 |
| ▸ | CACNA1C | Q13936 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10022715 | 1.00 | CACNA2D1 (0.39) | CACNA2D1CACNB2CACNA1C | |
| SCHEMBL4462408 | 0.91 | CACNA2D1 (0.41) | CACNA2D1CACNB2CACNA1C | |
| SCHEMBL29537640 | 0.91 | CACNA2D1 (0.41) | CACNA2D1CACNB2CACNA1C | |
| SCHEMBL717351 | 0.88 | CACNA2D1 (0.34) | CACNA2D1CACNB2CACNA1C | |
| SCHEMBL10090590 | 0.85 | CACNA2D1 (0.38) | CACNA2D1CACNB2CACNA1C | |
| SCHEMBL10034265 | 0.85 | BCHE (0.32) | CACNA2D1CACNB2CACNA1C | |
| SCHEMBL17231135 | 0.83 | CACNA2D1 (0.36) | CACNA2D1CACNB2CACNA1C | |
| SCHEMBL21821368 | 0.83 | CYP1A2 (0.33) | CACNA2D1CACNB2CACNA1C | |
| SCHEMBL718325 | 0.81 | ALDH1A1 (0.31) | — | |
| SCHEMBL14514097 | 0.81 | CACNA2D1 (0.35) | CACNA2D1CACNB2CACNA1C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2649082-B1 | NON-LINEAR ACENE DERIVATIVES AND THEIR USE AS ORGANIC SEMICONDUCTORS | MERCK PATENT GMBH (DE) | 2015-01-14 | — | — | EP | disclosed |
| US-20130248771-A1 | NON-LINEAR ACENE DERIVATIVES AND THEIR USE AS ORGANIC SEMICONDUCTORS | MERCK PATENT GMBH (DE) | 2013-09-26 | — | — | US | disclosed |
| US-20120048377-A1 | PHOTOSENSITIVE OPTOELECTRONIC DEVICES COMPRISING POLYCYCLIC AROMATIC COMPOUNDS | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2012-03-01 | — | — | US | disclosed |
| US-20120048377-A1 | PHOTOSENSITIVE OPTOELECTRONIC DEVICES COMPRISING POLYCYCLIC AROMATIC COMPOUNDS | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2012-03-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120048377-A1 | PHOTOSENSITIVE OPTOELECTRONIC DEVICES COMPRISING POLYCYCLIC AROMATIC COMPOUNDS | TYR, PAH, DDT | CACNA2D1 1837/4885CACNB2 2464/4885CACNA1C 1891/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.